The platform functions by translating complex FDA drug labeling and clinical data into plain language, allowing users to identify potential interactions and contraindications. It operates on a model of total anonymity, requiring no personally identifiable information to generate reports. By processing data from over 31,000 health conditions and 14,000 medications, the system aims to close the transparency gap that often leaves patients uninformed until after a prescription is issued.
In section Releases
Get a Second Opinion Debuts Anonymous Medication Intelligence Platform
Ninety-seven percent of early platform users report finding improved medication plans, according to data released today by Danville-based startup Get a Second Opinion. The company launched a national pre-prescription intelligence system designed to provide patients with safety, efficacy, and cost analysis before they ever visit a pharmacy.
Beyond individual use, the company has developed an enterprise API for hospitals, insurers, and research institutions to integrate these insights into existing clinical workflows. CEO Joel Ferman emphasizes that the goal is to shift patient agency to the start of the treatment process rather than the end. Supported by Google and the NVIDIA Inception Program, the engine benchmarks medications against hundreds of regulatory records, providing users with a comprehensive view of side-effect profiles and cost-effective alternatives.
Comments (0)
No comments yet. Be the first!